Introduction: FOXO4-DRI peptide allows selective apoptosis of senescent cells, supports metabolic experiments, and ensures steadiness in investigate, enhancing reproducibility and advancing growing old and oncology investigations. every day laboratory workflows typically expose gaps in which existing compounds fall short to address mobile senescen